microarray-based gene expression analysis protocol (Arraystar inc)
90
Structured Review
Arraystar inc
microarray-based gene expression analysis protocol
Microarray Based Gene Expression Analysis Protocol, supplied by Arraystar inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microarray-based+gene+expression+analysis+protocol/gene+expression+microarray+analysis/pm39096478-76-13-13
Average 90 stars, based on 1 article reviews
Microarray Based Gene Expression Analysis Protocol, supplied by Arraystar inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microarray-based+gene+expression+analysis+protocol/gene+expression+microarray+analysis/pm39096478-76-13-13
Average 90 stars, based on 1 article reviews
microarray-based gene expression analysis protocol - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Microarray:Article Title: A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1 Article Snippet: Article Title: Synergistic Effects of Glutamine Deprivation and Metformin in Acute Myeloid Leukemia. Article Snippet: [Abstract] Objective: The metabolic reprogramming of acute myeloid leukemia (AML) cells is a compensatory adaptation to meet energy requirements for rapid proliferation.. This study aimed to examine the synergistic effects of glutamine deprivation and metformin exposure on AML cells.. Methods: SKM-1 cells (an AML cell line) were subjected to glutamine deprivation and/or treatment with metformin or bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl) ethyl sulfide (BPTES, a glutaminase inhibitor) or cytarabine. Labeling:Article Title: A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1 Article Snippet: Article Title: Synergistic Effects of Glutamine Deprivation and Metformin in Acute Myeloid Leukemia. Article Snippet: [Abstract] Objective: The metabolic reprogramming of acute myeloid leukemia (AML) cells is a compensatory adaptation to meet energy requirements for rapid proliferation.. This study aimed to examine the synergistic effects of glutamine deprivation and metformin exposure on AML cells.. Methods: SKM-1 cells (an AML cell line) were subjected to glutamine deprivation and/or treatment with metformin or bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl) ethyl sulfide (BPTES, a glutaminase inhibitor) or cytarabine. Hybridization:Article Title: A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1 Article Snippet: Article Title: Synergistic Effects of Glutamine Deprivation and Metformin in Acute Myeloid Leukemia. Article Snippet: [Abstract] Objective: The metabolic reprogramming of acute myeloid leukemia (AML) cells is a compensatory adaptation to meet energy requirements for rapid proliferation.. This study aimed to examine the synergistic effects of glutamine deprivation and metformin exposure on AML cells.. Methods: SKM-1 cells (an AML cell line) were subjected to glutamine deprivation and/or treatment with metformin or bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl) ethyl sulfide (BPTES, a glutaminase inhibitor) or cytarabine. Expressing:Article Title: A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1 Article Snippet: Article Title: Synergistic Effects of Glutamine Deprivation and Metformin in Acute Myeloid Leukemia. Article Snippet: [Abstract] Objective: The metabolic reprogramming of acute myeloid leukemia (AML) cells is a compensatory adaptation to meet energy requirements for rapid proliferation.. This study aimed to examine the synergistic effects of glutamine deprivation and metformin exposure on AML cells.. Methods: SKM-1 cells (an AML cell line) were subjected to glutamine deprivation and/or treatment with metformin or bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl) ethyl sulfide (BPTES, a glutaminase inhibitor) or cytarabine. Over Expression:Article Title: A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1 Article Snippet: Article Title: Synergistic Effects of Glutamine Deprivation and Metformin in Acute Myeloid Leukemia. Article Snippet: [Abstract] Objective: The metabolic reprogramming of acute myeloid leukemia (AML) cells is a compensatory adaptation to meet energy requirements for rapid proliferation.. This study aimed to examine the synergistic effects of glutamine deprivation and metformin exposure on AML cells.. Methods: SKM-1 cells (an AML cell line) were subjected to glutamine deprivation and/or treatment with metformin or bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl) ethyl sulfide (BPTES, a glutaminase inhibitor) or cytarabine. Western Blot:Article Title: A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1 Article Snippet: Article Title: Synergistic Effects of Glutamine Deprivation and Metformin in Acute Myeloid Leukemia. Article Snippet: [Abstract] Objective: The metabolic reprogramming of acute myeloid leukemia (AML) cells is a compensatory adaptation to meet energy requirements for rapid proliferation.. This study aimed to examine the synergistic effects of glutamine deprivation and metformin exposure on AML cells.. Methods: SKM-1 cells (an AML cell line) were subjected to glutamine deprivation and/or treatment with metformin or bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl) ethyl sulfide (BPTES, a glutaminase inhibitor) or cytarabine. Software:Article Title: A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1 Article Snippet: Article Title: Synergistic Effects of Glutamine Deprivation and Metformin in Acute Myeloid Leukemia. Article Snippet: [Abstract] Objective: The metabolic reprogramming of acute myeloid leukemia (AML) cells is a compensatory adaptation to meet energy requirements for rapid proliferation.. This study aimed to examine the synergistic effects of glutamine deprivation and metformin exposure on AML cells.. Methods: SKM-1 cells (an AML cell line) were subjected to glutamine deprivation and/or treatment with metformin or bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl) ethyl sulfide (BPTES, a glutaminase inhibitor) or cytarabine. Transfection:Article Title: A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1 Article Snippet: Article Title: Synergistic Effects of Glutamine Deprivation and Metformin in Acute Myeloid Leukemia. Article Snippet: [Abstract] Objective: The metabolic reprogramming of acute myeloid leukemia (AML) cells is a compensatory adaptation to meet energy requirements for rapid proliferation.. This study aimed to examine the synergistic effects of glutamine deprivation and metformin exposure on AML cells.. Methods: SKM-1 cells (an AML cell line) were subjected to glutamine deprivation and/or treatment with metformin or bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl) ethyl sulfide (BPTES, a glutaminase inhibitor) or cytarabine. Plasmid Preparation:Article Title: A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1 Article Snippet: Article Title: Synergistic Effects of Glutamine Deprivation and Metformin in Acute Myeloid Leukemia. Article Snippet: [Abstract] Objective: The metabolic reprogramming of acute myeloid leukemia (AML) cells is a compensatory adaptation to meet energy requirements for rapid proliferation.. This study aimed to examine the synergistic effects of glutamine deprivation and metformin exposure on AML cells.. Methods: SKM-1 cells (an AML cell line) were subjected to glutamine deprivation and/or treatment with metformin or bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl) ethyl sulfide (BPTES, a glutaminase inhibitor) or cytarabine. Inhibition:Article Title: A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1 Article Snippet: Article Title: Synergistic Effects of Glutamine Deprivation and Metformin in Acute Myeloid Leukemia. Article Snippet: [Abstract] Objective: The metabolic reprogramming of acute myeloid leukemia (AML) cells is a compensatory adaptation to meet energy requirements for rapid proliferation.. This study aimed to examine the synergistic effects of glutamine deprivation and metformin exposure on AML cells.. Methods: SKM-1 cells (an AML cell line) were subjected to glutamine deprivation and/or treatment with metformin or bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl) ethyl sulfide (BPTES, a glutaminase inhibitor) or cytarabine. Activity Assay:Article Title: A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1 Article Snippet: Article Title: Synergistic Effects of Glutamine Deprivation and Metformin in Acute Myeloid Leukemia. Article Snippet: [Abstract] Objective: The metabolic reprogramming of acute myeloid leukemia (AML) cells is a compensatory adaptation to meet energy requirements for rapid proliferation.. This study aimed to examine the synergistic effects of glutamine deprivation and metformin exposure on AML cells.. Methods: SKM-1 cells (an AML cell line) were subjected to glutamine deprivation and/or treatment with metformin or bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl) ethyl sulfide (BPTES, a glutaminase inhibitor) or cytarabine. Quantitative RT-PCR:Article Title: A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1 Article Snippet: Article Title: Synergistic Effects of Glutamine Deprivation and Metformin in Acute Myeloid Leukemia. Article Snippet: [Abstract] Objective: The metabolic reprogramming of acute myeloid leukemia (AML) cells is a compensatory adaptation to meet energy requirements for rapid proliferation.. This study aimed to examine the synergistic effects of glutamine deprivation and metformin exposure on AML cells.. Methods: SKM-1 cells (an AML cell line) were subjected to glutamine deprivation and/or treatment with metformin or bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl) ethyl sulfide (BPTES, a glutaminase inhibitor) or cytarabine. |
